Search results
AbbVie, Eli Lilly exit UK drug pricing agreement
Reuters via Yahoo! Philippines News· 1 year agoCompanies are increasingly arguing that it is no longer possible to justify the UK's "voluntary scheme" to global boardrooms and investors as repayment...
Biden team, Eli Lilly condemn new Indiana abortion ban
Associated Press via Yahoo! Philippines News· 2 years agoThe administration of President Joe Biden and one of Indiana's largest employers have condemned the...
Lilly to cut some list prices by 70% and offer $25 insulin
Reuters via Yahoo! Philippines News· 1 year ago(Reuters) -Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly...
Exclusive-Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs
Reuters via Yahoo! Philippines News· 1 year agoEli Lilly and Co expects the U.S. Medicare health plan to back down from strict coverage limits on...
Fed, jobs data to set groundwork for rest of 2022: What to know this week
Yahoo Finance· 2 years agoThe Federal Reserve’s next policy move and a rush of employment data will headline a busy start to...
Why stocks rally when everything else is getting worse: Morning Brief
Yahoo Finance· 2 years agoThis article first appeared in the Morning Brief. Get the Morning Brief sent directly to your inbox...
Eli Lilly's insulin copay cap doesn't replace the need for government regulation
Quartz via Yahoo! Philippines News· 1 year agoA few months after congress failed to pass an insulin copay cap of $35 for all insured patients, and...
Twitter Blue signups unavailable after raft of fake accounts
Associated Press via Yahoo! Philippines News· 2 years agoTwitter's relaunched premium service — which grants blue-check “verification” labels to anyone...
Stocks slide after Fed announces 0.25% rate hike: Stock market news today
Yahoo Finance· 1 year agoU.S. stocks fell on Wednesday after the Federal Reserve hinted at a potential pause to its...
Eli Lilly: Positive results on its new Alzheimer's drug
Yahoo Finance· 1 year agoEli Lilly (LLY) reported positive results for its Alzheimer's drug, donanemab, and plans to file for...